Czechia· CZ-0018131

SARTEN

A olmesartan medoxomil product containing olmesartan medoxomil, registered in Czechia by Menarini International Operations Luxembourg S.A., Luxembourg. The same ATC class is registered in 15 of our 19 countries.

ATC C09CA08

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSARTENATCC09CA08REGISTER NO.CZ-0018131PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Olmesartan medoxomil is registered in 15 of 19 countries.

Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 10 of them publish a price we can compare per daily dose

Olmesartan medoxomil · ATC C09CA08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olmesartan medoxomil costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Olmesartan medoxomil · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.86
  • ES Spain$0.41
  • IT Italy$0.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
OLMESARTAN MEDOXOMIL
Manufacturer
Menarini International Operations Luxembourg S.A., Luxembourg
Country
Czechia (CZ)
ATC code
C09CA08
ATC class
Olmesartan medoxomil
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for olmesartan medoxomil.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Olmesartan medoxomil · interactions on record

216 records

  • 7 severe
  • 128 moderate

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium gluconateA12BA05severe
  • Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Mencord, Olmeblo
  • Belgium · Belsar, Olmesartan Ab
  • Bulgaria · Tansidor, Амлосарт
  • Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
  • Germany · Olmecor, Olmes
  • Denmark · Olmesartan Medoxomil Krka
  • Estonia · Mesar, Olimestra
  • Spain · Atolme, Ixia
  • Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
  • France · Alteis, Olmetec
  • United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
  • Greece · Ipertas, Olmesartan Sandoz
  • Croatia · Olimestra, Olmesartan Genericon
  • Hungary · Laresin
  • Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
  • Italy · Cardol, Idalman
  • Lithuania · Mesar, Olimestra
  • Luxembourg · Belsar, Olmesartan Eg
  • Latvia · Mesar, Olimestra
  • Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
  • Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
  • Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
  • Poland · Olimestra, Olmesartan Lek-Am
  • Portugal · Atolme, Condronac
  • Romania · Olmetec, Santini
  • Slovenia · Olimestra, Tensiol
  • Slovakia · Tenzar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6af2c2c2-947b-4d60-bcb6-da3cbbbdb1bb
GET /v1/drugs/6af2c2c2-947b-4d60-bcb6-da3cbbbdb1bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "20MG",
  "pack_size": "10X28",
  "substance": "OLMESARTAN MEDOXOMIL",
  "cz_kod_sukl": "0018131",
  "product_type": "CH",
  "substance_codes": "15600",
  "registration_state": "R",
  "registration_number": "58/075/05-C"
}

See everything about olmesartan medoxomil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.